Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7806-7813
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7806
Table 2 Comparison of baseline characteristics between the sufentanil and butorphanol groups

Sufentanil group (n = 55)
Butorphanol group (n = 55)
P value
Age71.0 ± 5.769.6 ± 5.70.199
Gender (male/female)32/2334/210.698
ASA (I/II/III)0/33/220/30/250.847
Weight (kg)63.6 ± 10.368.6 ± 11.30.058
BMI (kg/m2)21.1 ± 1.820.81 ± 1.70.403
Smoking (yes/no)25/3026/290.703
PONV or motion sickness history (yes/no)14/4120/350.218
Operation time (h)3.41 ± 1.303.25 ± 1.070.484
Intraoperative infusion volume (mL)1290.9 ± 404.71243.6 ± 316.80.497
Postoperative 24-h infusion volume (mL)2380.9 ± 137.62342.7 ± 133.80.143
Postoperative 48-h infusion volume (mL)2152.7 ± 128.92125.5 ± 117.40.249